Stone Centre at Vancouver General Hospital, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
J Urol. 2010 Feb;183(2):765-71. doi: 10.1016/j.juro.2009.09.073.
Ureteral stents are commonly used to facilitate kidney drainage but they may produce significant stent symptoms and morbidity, and require a secondary procedure for removal. Previous biodegradable stents showed bio-incompatibility or inconsistent degradation, requiring extra procedures to remove undegraded stent fragments. We previously reported a first generation biodegradable stent composed of suture-like material that required placement through the lumen of a sheath and degraded by 10 weeks. We now report second and third generation biodegradable stents that degrade more rapidly and can be placed directly over a polytetrafluoroethylene guidewire.
Two groups of 16 Yucatan pigs each were unilaterally stented endoscopically with a control nondegradable (biostable) stent or a second generation degradable Uriprene stent. Blood studies, renal ultrasound and excretory urography were done throughout the study to determine renal function, hydronephrosis and stent degradation. Genitourinary organs were harvested at necropsy for pathological analysis. A third generation stent designed to improve degradation time was bilaterally implanted endoscopically into 4 Yorkshire Farm pigs (total of 8 stents), followed by excretory urography weekly to assess degradation and kidney function. Biomaterial parameters were tested.
Second generation stents began degrading at 2 weeks and were completely degraded by 10 weeks. All third generation stents were degraded by 4 weeks. Hydronephrosis was considerably less in the Uriprene group than in control biostable stented kidneys. Biostable stented ureters showed an average higher degree of inflammation, uropathy and nephropathy. Physical characteristics indicate that Uriprene stents are significantly more resistant to stent compression and have markedly higher tensile strength and coil strength comparable to that of other commercially available plastic stents.
Our study confirms that Uriprene stents are biocompatible and provide good renal drainage. They hold promise for decreasing the need for a secondary procedure and stent related morbidity, such as infection and irritative symptoms.
输尿管支架通常用于促进肾脏引流,但它们可能会产生显著的支架症状和发病率,并需要进行二次手术取出。以前的可生物降解支架表现出生物不相容性或不一致的降解,需要额外的程序来去除未降解的支架碎片。我们之前报道了第一代由缝合线样材料组成的可生物降解支架,该支架需要通过护套的管腔放置,并在 10 周内降解。我们现在报告第二代和第三代可生物降解支架,它们的降解速度更快,可以直接放在聚四氟乙烯导丝上。
两组各 16 只 Yucatan 猪,每组均经内镜单侧放置不可降解(生物稳定)支架或第二代可降解 Uriprene 支架。在整个研究过程中进行血液研究、肾脏超声和排泄性尿路造影,以确定肾功能、肾积水和支架降解情况。尸检时采集泌尿生殖器官进行病理分析。第三代表皮设计为改善降解时间,将其双侧经内镜植入 4 只约克夏农场猪(共 8 个支架),然后每周进行排泄性尿路造影,以评估降解和肾功能。测试生物材料参数。
第二代支架在 2 周时开始降解,在 10 周时完全降解。所有第三代支架均在 4 周时降解。Uriprene 组的肾积水明显少于对照组生物稳定支架肾。生物稳定支架输尿管表现出较高程度的炎症、尿路病和肾病。物理特性表明,Uriprene 支架对支架压缩的抵抗力明显更强,拉伸强度和线圈强度明显高于其他市售塑料支架。
我们的研究证实 Uriprene 支架具有生物相容性,可提供良好的肾脏引流。它们有望减少二次手术和支架相关发病率的需求,如感染和刺激性症状。